- $283.54m
- $228.80m
- $211.48m
- 17
- 55
- 28
- 25
2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | fx Final | fx Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 206 | 64.9 | 773 | 652 | 211 |
Cost of Revenue | |||||
Gross Profit | -74.7 | 5.47 | 442 | 230 | -241 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 359 | 102 | 490 | 609 | 622 |
Operating Profit | -153 | -36.8 | 283 | 42.9 | -411 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -150 | -31.2 | 317 | 88.3 | -465 |
Provision for Income Taxes | |||||
Net Income After Taxes | -150 | -31.2 | 309 | 69.9 | -414 |
Net Income Before Extraordinary Items | |||||
Net Income | -150 | -31.2 | 309 | 69.9 | -414 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -150 | -31.2 | 309 | 69.9 | -414 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.063 | -0.013 | 0.12 | 0.03 | -0.154 |